Menorrhagia is most common in adolescence and in perimenopause—both are times of the lifecycle in which estrogen exposure exceeds and is out of balance with progesterone. Most women with menorrhagia report regular periods and have been shown to have normal estrogen and progesterone levels. In a study using a dilatation and curettage surgery (D & C) for all women with heavy flow.
33% of women describe their periods as heavy. The perception of what is heavy menstrual bleeding is subjective and 30% of women consider their bleeding excessive. However only half of these women fit the clinical criteria of greater than 80 mls of blood loss per cycle. DUB is more common around the menarche and perimenopause.
In some cases, heavy periods do not need to be treated, as they can be a natural variation and may not disrupt your lifestyle. If treatment is necessary, medication is most commonly used first. However, it may take a while to find the medication most suitable for you, as their effectiveness is different for everyone and some also act as contraceptives. If medication doesn't work, surgery may also be an option.
Major research on disease:
Outpatient transcervical microwave myolysis assisted by transabdominal ultrasonic guidance for menorrhagia caused by submucosal myomas.Treatment options will depend on the cause of menorrhagia, the severity of menorrhagia and the overall health of the patient. Some common treatments include iron supplements, oral contraceptives, ibuprofen, and progesterone.